| Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs T Vasconcelos, B Sarmento, P Costa Drug discovery today 12 (23-24), 1068-1075, 2007 | 2054 | 2007 |
| Amorphous solid dispersions: Rational selection of a manufacturing process T Vasconcelos, S Marques, J das Neves, B Sarmento Advanced drug delivery reviews 100, 85-101, 2016 | 386 | 2016 |
| Gellan gum/pectin beads are safe and efficient for the targeted colonic delivery of resveratrol FG Prezotti, FI Boni, NN Ferreira, DS Silva, SP Campana-Filho, A Almeida, ... Polymers 10 (1), 50, 2018 | 48 | 2018 |
| Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems T Vasconcelos, S Marques, B Sarmento European Journal of Pharmaceutics and Biopharmaceutics 123, 1-8, 2018 | 43 | 2018 |
| Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile T Vasconcelos, F Araujo, C Lopes, A Loureiro, J das Neves, S Marques, ... European journal of pharmaceutical sciences 137, 105011, 2019 | 40 | 2019 |
| Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol T Vasconcelos, F Prezotti, F Araújo, C Lopes, A Loureiro, S Marques, ... International Journal of Pharmaceutics 595, 120245, 2021 | 39 | 2021 |
| Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol FG Prezotti, FI Boni, NN Ferreira, DS Silva, A Almeida, T Vasconcelos, ... Drug Development and Industrial Pharmacy 46 (2), 236-245, 2020 | 39 | 2020 |
| Development of a rapid dissolving ibuprofen solid dispersion T Vasconcelos, P Costa Pharm Res 16, 676-681, 2007 | 37 | 2007 |
| The biopharmaceutical classification system of excipients Vasconcelos, Teofilo, S Marques, bruno Sarmento Therapeutic delivery 8 (2), 65-78, 2017 | 35 | 2017 |
| Pharmaceutical composition for poorly soluble drugs TC De Vasconcelos US Patent App. 12/920,025, 2011 | 21 | 2011 |
| Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers C Fontes-Ribeiro, T Macedo, T Nunes, C Neta, T Vasconcelos, ... Drugs in R & D 9, 447-454, 2008 | 19 | 2008 |
| Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent 9,132,094, 2015 | 13 | 2015 |
| Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same TC de Vasconcelos, RJDS Lima, PMDC Barrocas, LS de Castro Pereira, ... | 13 | 2010 |
| Polymer-based delivery systems for oral delivery of peptides and proteins B Sarmento, D Ferreira, T Vasconcelos Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic …, 2009 | 13 | 2009 |
| Bioequivalence of final tablet formulation and research tablet formulation of eslicarbazepine acetate in healthy volunteers R Lima, T Vasconcelos, R Cerdeira, M Lefebvre, E Sicard J Bioequiv Availab 1 (3), 93-98, 2009 | 11 | 2009 |
| Pharmaceutical composition comprising licarbazepine acetate TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent 8,372,431, 2013 | 9* | 2013 |
| Pharmaceutical composition comprising licarbazepine acetate TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent 8,372,431, 2013 | 8 | 2013 |
| Pharmaceutical composition comprising licarbazepine acetate TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent 8,372,431, 2013 | 8 | 2013 |
| Pharmaceutical composition comprising licarbazepine acetate TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent 8,372,431, 2013 | 8 | 2013 |
| Composition TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa US Patent App. 12/257,240, 2009 | 8 | 2009 |
Bruno Sarmentoi3S - University of PortoVerified email at ineb.up.pt
